Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30498033.
- Also identified by DOI 10.1073/pnas.1807499115 and PMC identifier 6304938.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
TNF is a multifunctional cytokine involved in autoimmune disease pathogenesis that exerts its effects through two distinct TNF receptors, TNFR1 and TNFR2. While TNF- and TNFR1-deficient (but not TNFR2-deficient) mice show very similar phenotypes, the significance of TNFR2 signaling in health and disease remains incompletely understood. Recent studies implicated the importance of the TNF/TNFR2 axis in T regulatory (T<sub>reg</sub>) cell functions. To definitively ascertain the significance of TNFR2 signaling, we generated and validated doubly humanized TNF/TNFR2 mice, with the option of conditional inactivation of TNFR2. These mice carry a functional human TNF-TNFR2 (hTNF-hTNFR2) signaling module and provide a useful tool for comparative evaluation of TNF-directed biologics. Conditional inactivation of TNFR2 in FoxP3<sup>+</sup> cells in doubly humanized TNF/TNFR2 mice down-regulated the expression of T<sub>reg</sub> signature molecules (such as FoxP3, CD25, CTLA-4, and GITR) and diminished T<sub>reg</sub> suppressive function in vitro. Consequently, T<sub>reg</sub>-restricted TNFR2 deficiency led to significant exacerbation of experimental autoimmune encephalomyelitis (EAE), accompanied by reduced capacity to control Th17-mediated immune responses. Our findings expose the intrinsic and beneficial effects of TNFR2 signaling in T<sub>reg</sub> cells that could translate into protective functions in vivo, including treatment of autoimmunity.
Medical subject headings
- Autoimmunity
- Central Nervous System
- Disease Models, Animal
- Encephalomyelitis, Autoimmune, Experimental
- Receptors, Tumor Necrosis Factor, Type II
- T-Lymphocytes, Regulatory
- Tumor Necrosis Factor-alpha